Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Type (PD-1 Inhibitor, PD-L1 Inhibitor, Others), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Others), By Region, By Competition

Published	Pages	Publisher	Report code
Nov 2023	180	TechSci Research	ASDR-642592

Published: Nov 2023 - Pages : 180 - Publisher : TechSci Research - Report code : ASDR-642592

1. Bristol-Myers Squibb Company.
2. AstraZeneca plc.
3. Merck KGaA
4. F. Hoffmann-La Roche Ltd
5. Regeneron Pharmaceuticals Inc
6. Pfizer Inc
7. Janssen Global Services
LLC
8. 4SC AG
9. Mirati Therapeutics Inc.
10. Ascentage Pharma.

In-vitro Colorectal Cancer Screening Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

This report can be of interest as well:

In-vitro Colorectal Cancer Screening Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019...

Published: April, 2024 | Report code: ASDR-663295